Home › Teva Pharmaceutical Industries Given New $46.00 Price Target at BMO Capital Markets
 

Keywords :   


Teva Pharmaceutical Industries Given New $46.00 Price Target at BMO Capital Markets

2014-03-02 18:23:35| Biotech - Topix.net

BMO Capital Markets' price objective would indicate a potential downside of 7.80% from the company's current price.

Tags: price capital target industries

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »